In today's article we are going to talk about 2023 Nobel Prize in Physiology or Medicine, a topic that you have probably heard about, but that you may not know all the details about. 2023 Nobel Prize in Physiology or Medicine is a topic that has aroused great interest in recent times, since its relevance and impact covers different areas. This is a topic that has been present throughout history, but is currently taking on special importance due to various factors. Throughout this article, we are going to delve into 2023 Nobel Prize in Physiology or Medicine to better understand its meaning, its impact and its relevance in today's society. Read on to find out everything you need to know about 2023 Nobel Prize in Physiology or Medicine!
Award
The 2023 Nobel Prize in Physiology or Medicine
Karikó (left) and Weissman (right) "for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19"
The 2023 Nobel Prize in Physiology or Medicine was awarded to Katalin Karikó (born 1955) and Drew Weissman (born 1959) "for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19".[2][3]
Katalin Karikó was born on January 17, 1955, in Szolnok, Hungary.[4] From the University of Szeged, she received a Ph.D. in biochemistry in 1982.[5] From 2013 to 2022, she was associated with BioNTech RNA Pharmaceuticals, first as a vice president and promoted to senior vice president in 2019. This company, a division of BioNTech, commercialized mRNA vaccines at a global scale.
Karikó, K., Buckstein, M., Ni, H. and Weissman, D.Suppression of RNA Recognition by Toll-like Receptors: The impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23, 165–175 (2005).
Karikó, K., Muramatsu, H., Welsh, F.A., Ludwig, J., Kato, H., Akira, S. and Weissman, D.Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol Ther 16, 1833–1840 (2008).
Anderson, B.R., Muramatsu, H., Nallagatla, S.R., Bevilacqua, P.C., Sansing, L.H., Weissman, D. and Karikó, K.Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation. Nucleic Acids Res. 38, 5884–5892 (2010).